GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 83 filers reported holding GOSSAMER BIO INC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38,299 | -40.8% | 30,396 | +2.0% | 0.00% | – |
Q4 2022 | $64,646 | -81.9% | 29,791 | -0.4% | 0.00% | -100.0% |
Q3 2022 | $358,000 | +44.9% | 29,899 | +1.4% | 0.00% | +50.0% |
Q2 2022 | $247,000 | -7.8% | 29,478 | -4.5% | 0.00% | +100.0% |
Q1 2022 | $268,000 | -28.3% | 30,870 | -6.6% | 0.00% | -50.0% |
Q4 2021 | $374,000 | -12.6% | 33,043 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $428,000 | +51.2% | 34,032 | -2.3% | 0.00% | +100.0% |
Q2 2021 | $283,000 | -7.2% | 34,840 | +5.5% | 0.00% | 0.0% |
Q1 2021 | $305,000 | -4.1% | 33,023 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $318,000 | -24.5% | 32,936 | -2.8% | 0.00% | -50.0% |
Q3 2020 | $421,000 | +6.9% | 33,881 | +11.8% | 0.00% | 0.0% |
Q2 2020 | $394,000 | +52.7% | 30,318 | +19.4% | 0.00% | +100.0% |
Q1 2020 | $258,000 | -38.6% | 25,385 | -5.5% | 0.00% | -50.0% |
Q4 2019 | $420,000 | -7.7% | 26,854 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $455,000 | +61.3% | 27,079 | +112.9% | 0.00% | +100.0% |
Q2 2019 | $282,000 | +84.3% | 12,721 | +79.7% | 0.00% | 0.0% |
Q1 2019 | $153,000 | – | 7,080 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |